Immunotherapy in Myeloma : A Theme Issue in Honor of Prof. Dr. Gösta Gahrton
Material type:
ArticleLanguage: English Publication details: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022Description: 1 electronic resource (124 p.)ISBN: - books978-3-0365-2907-3
- 9783036529073
- 9783036529066
- Medicine
- multiple myeloma
- immunotherapy
- daratumumab
- BCMA
- bi-specific T cell engagers
- chimeric antigen receptor
- relapse
- cytokine-release syndrome
- allogeneic transplantation
- myeloablative
- non-myeloablative
- new drugs
- CAR T
- antibodies
- monoclonal
- bispecific
- immunoconjugates
- antibody-drug conjugates
- myeloma
- NK cells
- immunomodulation
- cell therapy
- graft-versus-myeloma
- donor lymphocyte infusion
- allogeneic stem cell transplantation
- prophylaxis
- salvage
- CAR T-cells
- target antigen
- n/a
| Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Electronic-Books
|
OPJGU Sonepat- Campus | E-Books Open Access | Available |
Open Access star Unrestricted online access
Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.
Creative Commons https://creativecommons.org/licenses/by/4.0/ cc https://creativecommons.org/licenses/by/4.0/
English
There are no comments on this title.